Rizzoli R E, Murray T M, Marx S J, Aurbach G D
Endocrinology. 1983 Apr;112(4):1303-12. doi: 10.1210/endo-112-4-1303.
Binding of PTH to purified canine renal cortical membranes was investigated using biologically active radioiodinated bovine PTH-(1-84) [bPTH-(1-84)] as radioligand. PTH-(1-84) is thought to be the major circulating form of bioactive PTH, but oxidative inactivation upon iodination has prevented its use as a radioligand probe of PTH receptors. We have labeled PTH-(1-84) by a microelectrolytic constant current method to a high specific activity (180-220 muCi/micrograms), corresponding to an average ratio of 1 mol 125I/mol peptide. Affinity purification on chick renal membranes consistently improved the radioligand-binding properties, with a 6-fold increase in fraction specifically bound. Analysis of equilibrium (180 min at 15 C) competition curves showed two classes of binding sites for bPTH-(1-84). A high affinity binding site appeared to be coupled to activation of adenylate cyclase and exhibited affinity varying between 1.9 and 4.3 X 10(8) M-1. The affinity of this site for bPTH was decreased more than 50% by the nonhydrolyzable analog of GTP, guanyl-5'-yl-imidodiphosphate. A low affinity binding site also was detected (Ka = 0.6-6.2 X 10(6) M-1), and its affinity for bPTH was modulated by the concentration of magnesium. The high affinity sites exhibited hormonal specificity and guanine nucleotide dependency characteristic of peptide hormone receptors, while the low affinity sites did not. Analysis by polyacrylamide gel electrophoresis or high pressure liquid chromatography of the radioligand incubated with or released from purified canine renal cortical membranes revealed a single peak of radioactivity that comigrated with [125I]iodo-bPTH-(1-84). It appears from these studies that cleavage of amino-terminal to residue 43 ([125I]tyrosine) was not required for binding or release of hormone. These experiments indicate that radioiodinated bPTH-(1-84) is a useful probe for further characterization of PTH receptors in kidney and other organs.
使用具有生物活性的放射性碘化牛甲状旁腺激素 -(1 - 84)[bPTH -(1 - 84)]作为放射性配体,研究了甲状旁腺激素(PTH)与纯化的犬肾皮质膜的结合。PTH -(1 - 84)被认为是生物活性PTH的主要循环形式,但碘化时的氧化失活使其无法用作PTH受体的放射性配体探针。我们通过微电解恒流法将PTH -(1 - 84)标记到高比活度(180 - 220μCi/μg),对应于平均1摩尔125I/摩尔肽的比例。在鸡肾膜上进行亲和纯化持续改善了放射性配体结合特性,特异性结合部分增加了6倍。平衡(15℃下180分钟)竞争曲线分析显示bPTH -(1 - 84)有两类结合位点。一个高亲和力结合位点似乎与腺苷酸环化酶的激活相关,其亲和力在1.9至4.3×10(8)M - 1之间变化。该位点对bPTH的亲和力被GTP的不可水解类似物鸟苷 - 5'-基 - 亚氨基二磷酸降低了50%以上。还检测到一个低亲和力结合位点(Ka = 0.6 - 6.2×10(6)M - 1),其对bPTH的亲和力受镁浓度调节。高亲和力位点表现出肽激素受体特有的激素特异性和鸟嘌呤核苷酸依赖性,而低亲和力位点则没有。通过聚丙烯酰胺凝胶电泳或高压液相色谱分析与纯化的犬肾皮质膜孵育或从其释放的放射性配体,发现一个与[125I]碘 - bPTH -(1 - 84)共迁移的单一放射性峰。从这些研究看来,激素结合或释放不需要氨基末端切割至残基43([125I]酪氨酸)。这些实验表明放射性碘化bPTH -(1 - 84)是进一步表征肾脏和其他器官中PTH受体的有用探针。